FDA Drug Application (022224) for TRILIPIX by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number022224
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
DosageEQ 45MG FENOFIBRIC ACID
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRILIPIX
Active IngredientCHOLINE FENOFIBRATE



Back to FDA Applications sponsored by ABBVIE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.